# Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

> **NCT00809276** · PHASE1,PHASE2 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 92 (actual)

## Conditions studied

- Lymphoma
- Multiple Myeloma
- Leukemia
- Myelodysplastic Syndrome

## Interventions

- **DRUG:** Busulfan, Fludarabine, Cytoxan

## Key facts

- **NCT ID:** NCT00809276
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2015-02-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00809276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00809276, "Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00809276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*